Gelesis, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2006-02-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.gelesis.com
Clinical Trials
11
Active:0
Completed:8
Trial Phases
1 Phases
Not Applicable:11
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials
Not Applicable
11 (100.0%)Study on GS300 on NAFLD
Not Applicable
- Conditions
- Weight LossNonalcoholic Fatty Liver
- First Posted Date
- 2021-05-14
- Last Posted Date
- 2022-01-24
- Lead Sponsor
- Gelesis, Inc.
- Target Recruit Count
- 250
- Registration Number
- NCT04887766
Assessing GS500 in Functional Constipation
Not Applicable
- Conditions
- Constipation - Functional
- First Posted Date
- 2021-05-14
- Last Posted Date
- 2022-01-24
- Lead Sponsor
- Gelesis, Inc.
- Target Recruit Count
- 260
- Registration Number
- NCT04887896
Effects of Gelesis200 on Appetite Parameters, Food Intake, and Glycemic Control in Overweight or Obese Prediabetic Subjects: A Sub-Study of LIGHT-UP
Not Applicable
Completed
- Conditions
- PreDiabetesType2 DiabetesOverweight and Obesity
- First Posted Date
- 2018-08-09
- Last Posted Date
- 2022-04-04
- Lead Sponsor
- Gelesis, Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT03622424
- Locations
- 🇩🇰
University of Copenhagan, Frederiksberg, Denmark
Gelesis Glycemic Index Study
Not Applicable
Completed
- Conditions
- PreDiabetesObesityDiabetes
- First Posted Date
- 2017-04-21
- Last Posted Date
- 2018-02-15
- Lead Sponsor
- Gelesis, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT03124134
- Locations
- 🇨🇦
inVentiv Health Clinique, Quebec City, Canada
Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects w/o Type 2 Diabetes
Not Applicable
- Conditions
- PreDiabetesObesityOverweightDiabetes
- First Posted Date
- 2017-02-20
- Last Posted Date
- 2020-07-21
- Lead Sponsor
- Gelesis, Inc.
- Target Recruit Count
- 300
- Registration Number
- NCT03058029
- Locations
- 🇺🇸
Central Alabama Research, Birmingham, Alabama, United States
🇺🇸Meridien Research, Inc - Bradenton, Bradenton, Florida, United States
🇺🇸Baptist Diabetes Associates, P.A., Miami, Florida, United States
- Prev
- 1
- 2
- 3
- Next
News
No news found